Oramed Pharmaceutical Inc. Technology and Politics Essay -- Business A

Oramed Pharmaceutical Inc. TechnologyOramed is a contemporary pharmaceutical company that is in the main focussed into developing new cutting-edge medicinal diabetic drugs that throw away not been in existence before. Similar to other pharmaceutical companies, engineering is a key factor in the success such companies. In an exclusive interview on www.wallst.net with Nadav Kidron, Orameds CEO, he was quoted describing Oramed Pharmaceuticals Inc. as an Israeli company focused on the development of oral saving solutions base on proprietary technology (PR Newswire Association LLC, 2007). Kidrons comment demonstrates the comfort of technology to Oramed causing the company to patent its technology and product. Lately Oramed focused on the development of a new diabetic drug called ORMD0801. This product, in a form of a gel capsule, can be consumed orally. ORMD0801 in turn, plays a role in eliminating the need for insulin pitch by the style of self-injecting and constant painful testi ng of insulin blood levels. In order to progress to this function, Oramed will need sophisticated technology and certainly top-notch high-tech equipment. Therefore, Oramed has to in an ongoing basis to secure in-licensing and other means of obtaining additional technologies to full complement and/or expand its product portfolio (The New York Times, 2012).Orameds emerging ORMD0801 delivery is a technology in its-self. It advances the ability of the body to absorb peptides and proteins by means of the intestinal track wall without creating any changes to the active ingredients of the drug (Oramed, 2009). This was achievable by introducing a substitute drug delivery system (Oramed Pharmaceuticals Inc., 2010). This delivery system will successfully deliver the drug to ... ...012/03/20/idUS125396+20-Mar-2012+BW20120320 PR Newswire Association LLC. (2007). Exclusive Interview With Oramed Pharmaceuticals Inc. CEO, Nadav Kidron on www.Wallst.Net. PR Newswire. ProQuest Newsstand. http //proquest.umi.com/pqdlink?vinst=PROD&fmt=3&startpage=-1&vname=PQD&RQT=309&did=1256371181&scaling=FULL&vtype=PQD&rqt=309&TS=1333335886&clientId=20655PR Newswire Association LLC. (2009). Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European viva voce Drug Delivery Technology Innovation Award. PR Newswire. http//proquest.umi.com.ezproxy.liberty.edu2048/pqdlink?vinst=PROD&fmt=3&startpage=1&vname=PQD&RQT=309&did=1844533951&scaling=FULL&vtype=PQD&rqt=309&TS=1333049930&clientId=20655The New York Times. (2012). Business Day. Retrieved from NY Times.com http//topics.nytimes.com/top/ intelligence/business/companies/oramed-pharmaceuticals-inc/index.html